Sign in

CIK 0001645460

  • Non-accelerated filer
  • Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473324577
Phone
+1 617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
  1. 4 Open-market sale Director sold 24,700 shares at an average $16.28 ($402,209)
  2. 4 Open-market sale Director sold 36,647 shares at an average $17.20 ($630,352)
  3. 4 Open-market sale Director sold 24,732 shares at an average $15.94 ($394,114)
  4. 4 Shares withheld for taxes President and CSO gave up 12,087 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy CEO and President bought 1,377 shares at $7.26 ($9,997)
  9. 4 Open-market buy SVP, General Counsel and Sec bought 16,938 shares at an average $7.83 ($132,658)
  10. 4 Open-market buy CEO and President bought 3,000 shares at $6.90 ($20,700)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 5 Insider Annual Insider Trading Report
  19. 4 Open-market buy Director bought 10,000 shares at $4.81 ($48,100)
  20. 4 Derivatives Options or other derivatives

Page 10 of 13 · 259 filings